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Purpose: To investigate application of pre-treatment established correlations between bladder-ﬁlling
changes and cervix–uterus displacements in adaptive therapy.
Materials and methods: Thirteen cervical cancer patients participated in this prospective study. Pre-treat-
ment, and after delivery of 40 Gy, a full bladder CT-scan was acquired, followed by voiding the bladder
and acquisition of 4 other 3D scans in a 1 h period with a naturally ﬁlling bladder (variable bladder ﬁlling
CT-scans, VBF-scans). For the pre-treatment VBF-scans, linear correlations between bladder volume
change and displacements of the tip of the uterus (ToU) and the center of mass (CoM) of markers
implanted in the fornices of the vagina relative to the full bladder planning scan were established. Pre-
diction accuracy of these correlation models was assessed by comparison with actual displacements in
CT-scans, both pre-treatment and after 40 Gy. Inter-fraction ToU and marker-CoM displacements were
derived from the established correlations and twice-weekly performed in-room bladder volume mea-
surements, using a 3D ultrasound scanner.
Results: Target displacement in VBF-scans ranged from up to 65 mm in a single direction to almost 0 mm,
depending on the patient. For pre-treatment VBF-scans, the linear correlation models predicted the mean
3D position change for the ToU of 26.1 mm ± 10.8 with a residual of only 2.2 mm ± 1.7. For the marker-
CoM, the 8.4 mm ± 5.3 mean positioning error was predicted with a residual of 0.9 mm ± 0.7. After 40 Gy,
the mean ToU displacement was 26.8 mm ± 15.8, while prediction based on the pre-treatment correla-
tion models yielded a mean residual error of 9.0 mm ± 3.7. Target positioning errors in the fractioned
treatments were very large, especially for the ToU (18.5 mm ± 11.2 for systematic errors in SI-direction).
Conclusions: Pre-treatment acquired VBF-scans may be used to substantially enhance treatment preci-
sion of cervical cancer patients. Application in adaptive therapy is promising and warrants further inves-
tigation. For highly conformal (IMRT) treatments, the use of a full bladder drinking protocol results in
unacceptably large systematic set-up errors.
 2011 Elsevier Ireland Ltd. Open access under the Elsevier OA license.
Radiotherapy and Oncology 98 (2011) 340–346Cervical cancer patients may be treated with IMRT to reduce of-
ten observed side effects. However, several studies have reported
on the large extent and variability of internal-organ motion in
these patients [1–5]. To compensate for the geometrical uncertain-
ties, generous margins around the target volume are to be used,
reducing the positive impact of IMRT [6–9].
Changes in target position and shape in cervical cancer patients
may be caused by rectum- and bladder-ﬁlling changes, but may
also be due to tumor shrinkage during radiotherapy [5,7–9]. Most
of the published studies show that the largest impact is caused by
variations in bladder ﬁlling, especially for the uterus. A commonging and Radiotherapy Pro-
i Kebangsaan Malaysia, Jalan
a.
).
nder the Elsevier OA license.approach to limit bladder-ﬁlling changes is the use of drinking
instructions, aiming at daily treatment with a full bladder. How-
ever, the efﬁcacy of such a full bladder protocol is often limited,
i.e. large inter-fraction variability in bladder volume and signiﬁcant
volume decreases during treatment do still occur [10]. Therefore, it
is reasonable to expect considerable inter-fraction organ motion
related to bladder ﬁlling variations, at least for some patients.
Existence of patient-speciﬁc correlations between cervix–uterus
position/shape and bladder volume would point at a possibility to
estimate at the start of each fraction the internal cervix–uterus posi-
tion and shape from ameasured bladder volume. A ‘‘plan of the day’’
could then be selected fromapre-treatment created library of plans,
each designed for a different cervix–uterus position and shape,
related to a bladder volume. As a ﬁrst step in exploring the feasibility
of such a strategy, we investigated whether pre-treatment estab-
lished correlations between bladder volume and positions of two
R. Ahmad et al. / Radiotherapy and Oncology 98 (2011) 340–346 341points of interest (POI) in the complex cervix–uterus target can be
used to predict subsequent positions during fractionated treatment.
To this purpose, for each patient 3D CT scans with various bladder
ﬁllings were acquired at planning and after 40 Gy dose delivery.
For each CT-scan, the corresponding bladder volume was assessed
with ultrasound (US). For all patients, US bladder volume measure-
ments were also performed twice a week during fractionated treat-
ment. These in-room measured volumes and correlations between
bladder volumeandPOI-position, as derived fromCT-scans acquired
with various bladder ﬁllings, were used to generate distributions of
POI set-up deviations that occurred during the fractionated
treatments.Methods and materials
Patients and CT sessions
Thirteen patients with cervical cancer were included in this pro-
spective study. The distribution of FIGO (International Federation
of Gynaecology and Obstetrics) stages was as follows: IB: 1 patient,
IIA: 3 patients, IIB: 6 patients, IIIA: 1 patient, IIIB: 1 patient, and IV:
1 patient. The patients’ ages ranged from 26 to 67 years (median
49).
In accordance with our treatment protocol, all patients were
treated with external beam radiotherapy (EBRT). The doses at the
ICRU reference point were 46 or 50 Gy, which were delivered in
23 or 25 daily fractions of 2 Gy (4–5 weeks of full treatment
course). During the last weeks of the EBRT treatment, seven pa-
tients received a boost to the primary tumor by means of brachy-
therapy (BT) in two sessions of 8.5 Gy. For four patients, EBRT and
BT were combined with hyperthermia, and for two patients, EBRT
and BT were combined with chemotherapy. In an attempt to
achieve day-to-day reproducibility in bladder ﬁlling, the patients
were asked to drink 500 ml of water 1 h prior to each EBRT treat-
ment fraction. Patients were treated in prone position on a belly
board and with a foot rest.
All patients had 2–6 ﬁducial markers implanted in the fornices
of the vagina [11]. The patients had two CT-scanning sessions for
acquisition of CT-scans with various bladder ﬁllings, one at plan-
ning, the other after delivery of 40 Gy (Fig. 1). Each scan acquisition
was followed by a US bladder volume measurement. During treat-
ment, these volume measurements were also performed twice a
week, immediately after dose delivery. The study was approved
by the local ethics committee, and all patients provided written in-
formed consent before entering the study.
In each of the 2 sessions per patient, 5 3D CT-scans with
different bladder ﬁllings were acquired. As for the EBRT treatmentFig. 1. Protocols for (1) acquisition of pre-treatment (week 0) and after 40 Gy (week 5)
and (2) twice weekly in-room US measurements. For both CT-scanning sessions, all CTfractions (see above), patients were asked to drink 500 ml of water
1 h prior to each session. The ﬁrst scan was acquired immediately
at the start of a session, after positioning the patient in treatment
position on the belly board. After acquisition of this scan, the pa-
tient was asked to go to the toilet to empty her bladder, and then
drink another 300 ml. This was followed by acquisition of the other
4 CT scans on the belly board, acquired every 20 min while the
bladder ﬁlled naturally (in the remainder of this paper, these 4
scans are designated variable bladder ﬁlling CT-scans, VBF-scans).
Immediately after each acquisition, the bladder volume was mea-
sured using a portable 3-dimensional bladder US scanner (patient
supine) [10]. The ﬁrst CT scan in the ﬁrst session (acquired 1 h after
drinking 500 ml) was used as the planning CT scan for the actual
patient treatment. Scans were acquired from L1 to the anus with
a slice spacing of 3 mm. In total 128 3D CT-datasets were acquired.
Only one patient (patient 2) could not hold her full bladder before
the start of the protocol and she had to empty her bladder before
the acquisition of the ﬁrst CT scan. For that patient the ﬁrst CT scan
of the second series is missing. For another patient (patient 5) the
ﬁfth CT-scan of the ﬁrst series was incomplete due to technical
reasons.Correlations between bladder volume change and ToU and marker-
CoM motions
For these analyses, all acquired CT datasets in the ﬁrst and the
second CT sessions of a patient were ﬁrst registered to the planning
CT using bony anatomy of the pelvis. In this manner, bony anatomy
set-up variations (translations and rotations) were to a very large
extent removed, leaving mainly internal-organ motion.
The CT-scans and corresponding US bladder volumes obtained
in the pre-treatment CT session were used to derive linear correla-
tions between bladder volume changes and 3D motion of two POIs,
(1) the marker-CoM, and (2) the ToU. The positions in the planning
CT-scan were used as reference. In each scan, the ToU was marked
in an interactive process using sagittal, axial and coronal views (all
performed by a single observer, RA). The data were ﬁtted using lin-
ear models, i.e. for each patient POI one model per direction. From
this point on, the models obtained from the pre-treatment session
are referred to as planning models. To investigate the potential use
of these models for prediction of POI positions, we compared mea-
sured displacements of the POIs in the CT-scans of the planning
session with displacements predicted by the model.
To check applicability of the established planning correlations
for assessment of POI displacements during the fractionated treat-
ment (requiring constancy of the correlations), measured POI dis-
placements in the after 40 Gy CT-scans were compared withvariable bladder ﬁlling CT scans + corresponding US bladder volume measurements
scans were acquired in an approximately 1 h interval.
342 Adaptive RT using bladder and cervix-uterus correlationsdisplacements predicted with the corresponding US bladder vol-
umes and the planning models.POI positioning errors derived from in-room measured bladder
volumes
The bladder volumes obtained from the twice-weekly per-
formed US measurements were used to establish patient-speciﬁc
distributions of marker-CoM and ToU positioning errors for the
fractionated treatments of the patients in this study. For each in-
room measured bladder volume, POI positioning errors were esti-
mated both using the planning correlation model and the for this
purpose derived after-40-Gy model. The POI set-up error was then
deﬁned by the average of the outcome of both models. As men-
tioned above, in our clinical practice, a full bladder is aimed for
in all fractions, like in the planning CT scan. Nonetheless, position
deviations were also calculated, assuming that the planning CT-
scan was acquired with a half-full or empty bladder. In these anal-
yses, we used the half-full and empty bladder CT-scans acquired in
the ﬁrst CT session as virtual planning CT scans. For each (virtual)
planning scan, the overall mean set-up error for the patient group,
M, was calculated as the average of the per-patient mean set-up er-
ror during the fractionated treatment. The group systematic set-up
error R was calculated as the SD of the distribution of the per-pa-
tient mean errors. Standard deviations r, characterizing random
variations around the mean errors were determined by taking
averages of the patient SDs for these variations.Uncertainty in establishing the 3D position of the tip of the uterus in a
CT-scan
As markers are clearly visible in the various CT-scans, determin-
ing the marker-CoM in a scan can be done with little ambiguity.
This is different for the tip of the uterus. Therefore, for 5 arbitrary
patients in this study, the positions of the ToU in all 10 CT-scans
were determined twice by a single observer, with a time interval
of two months. The repeat measurements were performed without
access to the initial data. The acquired uncertainties are relevant
for interpretation of other data presented in this paper.
Results
Uncertainty in establishing the 3D position of the ToU in a CT-scan
For the twice established ToU positions in the 50 CT-scans in-
volved in this analysis, the overall mean differences in the two
observations in left–right (LR), inferior–superior (IS), and anterior–
posterior (AP) directions were 0.8, 1.0, and 1.0 mm, respectively.
For the same directions, the standard deviations describing the
inter-patient variation in mean difference between the ﬁrst and
second observations were 1.4, 1.9 and 1.7 mm. The standard devia-
tions describing the intra-patient variations were on average 4.6,
4.4, and 2.7 mm.Correlations between bladder volume change and ToU and marker-
CoM motions
The open symbols in Fig. 2 (see Supplementary data) show for
each patient and each direction, observed ToU motions in VBF-
scans acquired during the pre-treatment CT session. Large extents
of motion were found, especially in inferior and anterior directions
(up to 65 mm translation in anterior direction for patient 13 for the
empty bladder scan, Fig. 2c). The degree of displacement varied
widely from patient to patient. For example, patients 1 and 2 had
motion ranges of only 5 mm in the IS direction, while patients
4 and 7 show motion ranges of over 40 mm (Fig. 2b). The closedsymbols in Fig. 2 are deviations of measured displacements (open
symbols) from ﬁtted linear regression lines through the measured
data points. Fig. 3 shows data as in Fig. 2, but now for the marker-
CoM. Clearly, marker motion as a function of bladder volume
change is generally smaller than ToUmotion, but often of high clin-
ical relevance. For all patients and all directions, predictions re-
duced the uncertainty in the mean ToU and marker-CoM
positions. Figs. 2 and 3 are summarized in Table 1 (see Supplemen-
tary data). With prediction of ToU positions, the average patient
mean displacements reduced from 1.3 mm ± 5.7 (1 SD) to
0.3 mm ± 1.1, from 13.7 mm ± 8.7 to 0.8 mm ± 1.6, and from
10.6 mm ± 16.2 to 0.3 mm ± 1.9 for the LR, IS, and AP directions,
respectively (m and mres in Table 1). For the marker-CoM, these
reductions are from 1.2 mm ± 1.5 (1 SD) to 0.0 mm ± 0.2, from
4.0 mm ± 5.7 to 0.4 mm ± 0.7, and from 3.1 mm ± 6.3 to
0.1 mm ± 0.8. Displacement vector lengths decreased from
23.1 mm ± 10.8 to 2.2 mm ± 1.7, and from 8.4 mm ± 5.3 to
0.9 mm ± 0.7 for the ToU and marker-CoM, respectively. For almost
all patients/directions the overall displacement range also reduced,
with a few exemptions with a minor increase in range. For the
marker-CoM, standard deviations describing deviations of mea-
sured data from the linear ﬁts were, 0.8, 1.9 and 1.6 mm in LR, IS
and AP directions, respectively. For the ToU, these standard devia-
tions were 4.1, 5.8 and 5.0 mm.
Figs. 2 and 3 also show the slopes of the regression lines. For the
ToU, the mean slopes were: 0.0 mm/100 ml (range 2.8 to 0.9) for
the LR direction, 6.1 mm/100 ml (range 0.2 to +15.5) for the SI
direction, and 4.7 mm/100 ml (range 3.4 to +12.1) for the AP
direction. The mean slopes for the marker-CoM were 0.4 mm/
100 ml (range 1.1 to +0.9) for the LR direction, 1.2 mm/100 ml
(range 0.7 to +3.9) for the IS direction, and 1.5 mm/100 ml (range
1.7 to +3.0) for the AP direction. Statistically signiﬁcant non-zero
slopes for POI movement as a function of bladder-ﬁlling are
marked in Figs. 2 and 3.
For the after 40 Gy scans, Fig. 4 shows measured ToU displace-
ments versus displacements derived from the corresponding US
bladder volume measurements and planning correlations between
bladder volume and ToU motion. If the planning models would
have perfectly predicted the ToU positions after 40 Gy, all points
should lie on the unity lines. Certainly for large motions, position
predictions based on the planning models could have substantially
increased treatment precision after 40 Gy. In Fig. 4b and c, patients
1 and 11 show considerable deviations from the unity lines.
Inspection of the CT-scans learned that they both had large tumor
regression after 40 Gy dose delivery, probably resulting in the poor
prediction accuracy. For both the ToU and marker-CoM, compari-
sons between measured after 40 Gy displacements with residuals
after prediction with planning models are summarized in Table 2
(excluding patients 1 and 11, see above). For the ToU, the positive
impact of predictions demonstrated in Fig. 4 is clearly conﬁrmed
with a reduction in mean displacement vector length from
26.8 mm ± 15.8 to 9.0 mm ± 3.7. For the marker-CoM, prediction
accuracy of planning models is much smaller (Table 2b).POI set-up deviations derived from in-room measured bladder
volumes
Table 3a summarizes the estimated POI displacements as expe-
rienced by the patients in this study during their treatments
(excluding patients 1 and 11, see above). As described in detail in
the Material and methods, POI displacements were determined
using patient-speciﬁc correlations between bladder volume change
and POI motion as observed in CT scans with various bladder ﬁll-
ings. In agreement with our previous study [10], deviations from
full bladder as in the planning scan were frequent and large. Dur-
ing the fractionated treatments, patient systematic set-up errors
1 2 3 4 5 6 7 8 9 10 11 12 13
-30
-20
-10
0
10
20
30
Patient number
Tr
an
sl
at
io
n 
in
 L
R
 (m
m
)
1 2 3 4 5 6 7 8 9 10 11 12 13
-30
-20
-10
0
10
20
30
Patient number
Tr
an
sl
at
io
n 
in
 IS
 (m
m
)
R
L
S
I
-0.4*  0.9    -0.5*  -0.4   -0.7   -0.5*  -1.0*  -1.1*  -0.7* -0.7   0.0    -0.5    -0.2   mm/100ml       
0.2     2.2   -0.7*   1.3     0.2   -0.5*   3.9*   -0.6    0.9    1.8*   3.3*  3.0     -0.1  mm/100ml        
2a 
2b 
1 2 3 4 5 6 7 8 9 10 11 12 13
-30
-20
-10
0
10
20
30
Patient number
Tr
an
sl
at
io
n 
in
 A
P 
(m
m
)
P
A
1.0     0.7    2.3*   -1.7    3.0     0.5     0.6   2.1*   2.2*   2.3    2.4    2.0*   1.4*   mm/100ml        
2c 
Fig. 3. Open symbols: marker-CoM displacements relative to the planning CT-scan, as measured in variable bladder ﬁlling CT-scans acquired in the planning session. Closed
symbols: corresponding residual displacements after correction with the planning correlation models. The numbers above the graphs are slopes of the regression lines, ⁄
points at a slope that is statistically signiﬁcant different from 0. The displacements were calculated for four different CT scans; with empty bladder (h), after 20 min (s), after
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rior directions, respectively. Among patients there were also huge
variations in mean set-up error, R = 11.2 mm in IS direction and
R = 17.9 mm in AP direction. On top of this, in IS and AP directions
there were also large day-to-day variations in the ToU position (SD
8 mm). Table 3b and c show POI set-up deviations while assum-
ing that the planning CT-scan was acquired with a half full bladder
or empty bladder, respectively. Clearly, the overall mean set-up er-
rors during treatment (M) for the ToU and marker-CoM are best
represented by a planning CT-scan with a half full bladder. How-
ever, also for this scan, R- and r-values remain large, especially
for the ToU.
Discussion
We have investigated for cervical cancer patients treated prone
on a belly board, the feasibility of predicting cervix- and ToU
displacements during fractionated treatments, as resulting from
frequently occurring (large) inter-fraction bladder volume varia-
tions, even with a drinking protocol [10]. To exclude delineation
uncertainty in cervix analyses, we used the center of mass (CoM)
of markers implanted in the fornices as a surrogate for the cervix.
The assumption that we had to make herein is that marker-CoM
motion correlates with cervix motion (differences in absolute posi-
tions are irrelevant for the analyses). Predictions were based on
established patient-speciﬁc linear correlations between bladdervolume changes and displacements of these POI, as derived from
the planning CT-scan and VBF-scans. For the patients in this study
we also performed twice weekly bladder volume measurements
using a 3D ultrasound scanner. Correlations obtained using the
VBF-scans were then applied to estimate inter-fraction marker-
CoM and ToU motions that actually occurred during the fraction-
ated treatments.
The VBF-scans clearly demonstrate huge variation between pa-
tients in the extent of motion due to changes in bladder volume.
Some patients did hardly demonstrate any motion, while others
had motions up to 65 mm in a single direction. This observation
suggests that using a CTV-PTV margin recipe that should ensure
the vast majority of patients adequate tumor coverage, will for a
subgroup of patients lead to highly excessive dose delivery to
healthy tissues. Soon, acquisition of VBF-scans for treatment prep-
aration will become a standard practice in our institution. These
scans will then be used to individualize planning margins.
Several other studies also reported a considerable extent of
internal-organ motion in cervical cancer patients [2,4,5,12], with
displacements ranging from 8 mm up to 48 mm. van de Bunt
et al. [9] found that the change in the rectum correlated signiﬁ-
cantly but weakly with the motion of the cervix and uterus in
the AP direction. For the bladder the correlations were even weak-
er. We speculate that the weak correlation with bladder volume
could be explained by the fact that they evaluated the relationship
for the whole patient group, which weakened the correlation due
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Fig. 4. Measured and predicted ToU displacements in after 40 Gy variable bladder ﬁlling CT-scans. Predictions were performed using planning correlations.
Table 2
Tip-of-uterus (a) and marker (b) displacements observed in after 40 Gy variable bladder ﬁlling CT-scans for the LR, IS and AP directions. The last 2 columns relate to vector lengths.
The columns m, R, and d in (a) and (b) are descriptions of observed patient mean parameters in the variable bladder ﬁlling scans; m: patient mean displacements, R: patient mean
displacement ranges, d: patient mean displacement vector lengths. MEAN = mean of means, SD = standard deviation in patient mean values, MIN and MAX are minimum and
maximum patient mean parameters. Columns mres, Rres, and dres are descriptions of residual displacements after predictions with planning correlations between bladder ﬁlling
and POI-displacement.
LR IS AP d dres
m mres R Rres m mres R Rres m mres R Rres
(a) Tip-of-uterus displacements (mm)
MEAN 2.1 0.6 11.4 10.6 17.8 0.6 23.9 15.2 12.2 3.9 24.4 13.2 26.8 9.0
SD 7.1 4.1 7.2 5.4 10.5 6.9 13.0 8.5 18.9 4.6 14.2 8.2 15.8 3.7
MIN 6.6 4.7 4.2 3.6 31.5 10.9 4.8 4.8 51.4 2.5 8.5 2.9 7.2 3.0
MAX 18.1 9.7 24.4 19.6 3.1 9.7 46.7 33.8 9.3 12.0 50.2 25.9 57.8 15.1
(b) Marker displacements (mm)
MEAN 1.2 0.0 3.2 2.3 2.4 1.1 5.7 4.9 3.4 0.3 7.0 5.2 7.2 6.7
SD 2.8 2.7 2.7 1.2 4.5 6.2 4.8 2.0 5.8 3.5 3.6 2.2 4.9 3.2
MIN 2.9 3.8 0.7 0.5 10.1 9.1 0.7 2.1 15.7 6.5 3.5 2.7 2.1 2.8
MAX 6.8 5.3 9.1 4.5 4.6 10.0 15.7 8.5 6.1 4.8 16.8 10.3 18.7 11.4
344 Adaptive RT using bladder and cervix-uterus correlationsto large inter-patient variation in this correlation. Furthermore, the
measurements were spread out in time such that rectum ﬁlling
changes and tumor regression additionally weakened the correla-
tion. Another difference is that in their study the patients werescanned in supine position and not in prone using a belly board.
Most other studies support our data that the greater impact on
cervix–uterus motion is caused by variations in bladder ﬁlling
[1,5,8].
Table 3
Marker-CoM and tip-of-uterus position errors as derived from measured in-room
bladder volumes and established patient-speciﬁc correlations between bladder
volume changes and displacements. (a) reference = full bladder CT-scan (clinical),
(b) reference = half full bladder scan and, (c) reference = empty bladder scan.
Markers (mm) Tip of the uterus (mm)
LR IS AP LR IS AP
(a)
M 1.3 3.3 2.6 1.8 18.5 13.7
R 2.2 4.4 5.2 5.8 11.2 17.9
r 0.8 1.4 2.6 1.9 7.7 7.1
(b)
M 1.0 1.1 0.5 2.3 4.0 1.1
R 3.6 7.0 4.6 5.1 12.2 9.8
r 0.8 1.4 2.6 1.9 7.7 7.1
(c)
M 1.2 1.0 3.5 1.0 10.2 6.9
R 1.9 3.9 5.7 5.3 8.9 7.7
r 0.8 1.4 2.6 1.9 7.7 7.1
R. Ahmad et al. / Radiotherapy and Oncology 98 (2011) 340–346 345It was demonstrated that POI displacement with bladder vol-
ume change could be well described by linear regression lines.
For marker-CoM, deviations from the ﬁtted lines were 1–2 mm
(1 SD). For the ToU, the observed spread around the regression
lines was substantially larger, 5 mm (1 SD). However, repeat
assessments of the 3D position of the ToU in CT-scans for a subset
of patients showed an intra-patient variability of 5 mm (1 SD).
Therefore, the observed increase in spread of residual errors
around linear regression lines for the ToU, as compared to the mar-
ker-CoM, does not imply larger deviations from linearity. Obvi-
ously, the increased uncertainty in establishing the 3D ToU
position contributed to this observation.
As shown in Figs. 2 and 3, for many of the individual patient-
directions, there was no proof that the slope of the linear correla-
tion was statistically signiﬁcant, different from zero. On the other
hand, we noted that for all patient-directions, the mean residual
error after correction with the derived linear correlation model
was smaller than the mean of the original errors, both for the
ToU and marker-CoM and also for patient-directions with slopes
that were not statistically different from zero. Moreover, the reduc-
tions in mean error vector lengths for the ToU and marker-CoM
(dres versus d in Table 1) were highly statistically signiﬁcant
(p < 0.001, signed rank test). We believe that the difﬁculty in prov-
ing statistical signiﬁcance for the individual patient-directions is
related to the (unavoidably) small number of observations in-
volved, i.e. 4 3D CT-scans. Based on the arguments given here
and our view that correlation models have to be regularly checked
during the fractionated treatments as they may become invalid
due to tumor shrinkage (see below), all patients, except patients
1 and 11 with large tumor shrinkage, were included in the analyses
resulting in Tables 2 and 3.
Also after 40 Gy, position predictions for the ToU based on plan-
ning correlations resulted in clinically highly signiﬁcant reductions
in uncertainties (not for the two patients with large tumor regres-
sion after delivery of the ﬁrst 40 Gy). For marker-CoM, position
prediction in after 40 Gy scans, based on planning correlations,
seems less accurate. The latter ﬁnding may be related to a larger
sensitivity of marker-CoM position for tumor shrinkage or for
changes in rectal ﬁlling in the after 40 Gy CT session compared
to the planning session.
The twice-weekly performed US bladder volume measurements
revealed very large POI displacements relative to planning, espe-
cially for the ToU in the IS and AP directions, with mean errors of
18.5 mm ± 11.2 and 13.7 mm ± 17.9 in inferior and anterior direc-
tions, respectively (Table 3). This ﬁnding is in line with our previ-
ous observations of large and frequent deviations from the full
bladder that is aimed for [10]. Obviously, the patient anatomy inthe applied full bladder planning CT-scan is generally only a poor
representation of the mean anatomy during treatment. As varia-
tions in rectal ﬁlling and other uncertainties were not included in
these analyses, the full errors are even larger than those presented
here. Due to the target shape, the observed large target displace-
ments will generally not lead to severe under dosage in BEV-
planned four-ﬁeld box techniques. For highly conformal (IMRT)
treatments with considerable bladder sparing in the planning CT-
scan, great care is needed to avoid severe target under dosage in
the fractionated treatment. Because of the limited reproducibility
of the correlations between bladder ﬁlling and marker-CoM posi-
tion after 40 Gy dose delivery (possibly related to rectal ﬁlling vari-
ations or tumor shrinkage, see above), estimations of POI positions
from the in-room performed US were limited to the ToU.
The clinical potential for a substantial increase in treatment
precision for cervical cancer patients by using VBF-scans to assess
each individual patient, target motion with bladder volume
change, has been clearly demonstrated. More work needs to be
done to start clinical implementation in adaptive therapy. In on-
going investigations we focus on derivation of linear correlations
for the full target surface (instead of only ToU and marker-CoM).
These correlations are derived from VBF-scans, using deformable
image registration [13]. With this approach it will be possible to
predict the 3D target shape from a measured bladder volume. In
the current stage of clinical protocol development, the idea is to di-
vide patients in two groups, those with minor target motion with
bladder volume change, and those with large motion. The former
group will be treated with a reduced planning margin. For the lat-
ter, an adaptive approach is being developed, based on patient-spe-
ciﬁc libraries of treatment plans. Such a protocol should also take
into account intra-fraction motion of the uterus due to the ﬁlling
of the bladder. This error may be estimated for each patient sepa-
rately by calculating the target displacement from the patient spe-
ciﬁc bladder in-ﬂow rate, the patient-speciﬁc correlations between
bladder volume change and motion, and the time between in-room
bladder volume measurement and dose delivery. Important part of
the investigations is to also include set-up uncertainties related to
rectal ﬁlling variations. Here there may also be a role for the im-
planted ﬁducials that can be easily extracted in daily stereoscopic
2D or 3D kV imaging [11]. As we have observed, planning correla-
tions can become inaccurate in case of tumor shrinkage. Therefore,
clinical introduction will be accompanied by regular imaging dur-
ing the fractionated treatments for validation and update of the
planning correlations. Because of better soft tissue contrast, (also)
these imaging studies should preferentially be done with MRI. So
far we have decided to base the adaptive approach on patient-spe-
ciﬁc libraries of plans, on measured in-room bladder volumes using
a 3D US bladder scanner, and on two stereoscopic planar kV images
for marker detection. Alternatively, it would also be possible to
daily use cone beam CT-scans to measure both the bladder volume
and detect markers. This would, however, increase imaging dose
delivery to the patients. In theory, a daily cone beam CT-scan could
also be used to directly detect target motion followed by the selec-
tion of a treatment plan from the library of plans that was created
using the VBF-scans. However, we have experienced too much var-
iation in image quality between patients and from fraction to frac-
tion to consider this as the most promising approach at this time.
Possibly, this image quality issue could be related to the often large
patient diameters at the target level and to motion in the intestines
during scan acquisition.Conclusions
Motion of the cervix–uterus due to bladder ﬁlling variations
may be very large (up to 65 mm in a single direction) or almost
346 Adaptive RT using bladder and cervix-uterus correlationsabsent, depending on the patient. Motion ranges can be readily ob-
tained from variable bladder ﬁlling CT-scans. Linear correlations
between target point displacements and bladder volume changes,
as derived from these scans, have interesting potentials in adaptive
radiotherapy, with target deformations accounted for by different
correlations for all target points. The current approach of using full
bladder drinking instructions for planning CT-scan acquisition and
for daily treatment leads to large mean systematic set-up errors in
the fractioned treatments, especially for the tip of the uterus
(18.5 mm ± 11.2 in SI-direction).
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